MYLAN-CLOBETASOL SCALP APPLICATION
MYLAN PHARMACEUTICALS ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MYLAN-CLOBETASOL SCALP APPLICATION in Canada?
A shortage of MYLAN-CLOBETASOL SCALP APPLICATION 0.05% is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 6, 2026), but it has not started yet.
Why is MYLAN-CLOBETASOL SCALP APPLICATION not available?
The reason the manufacturer reported: Demand increase for the drug.
When will MYLAN-CLOBETASOL SCALP APPLICATION be available again?
The manufacturer's estimated resolution date is January 26, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
MYLAN-CLOBETASOL OINTMENT
MYLAN PHARMACEUTICALS ULC
MYLAN-CLOBETASOL CREAM
MYLAN PHARMACEUTICALS ULC
DERMOVATE OINTMENT
TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DERMOVATE SCALP APPLICATION
TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
NOVO-CLOBETASOL CRM 0.05%
NOVOPHARM LIMITED
PMS-CLOBETASOL CREAM
PHARMASCIENCE INC
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2027-01-26
~4 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02216213
Strength
0.05%
Dosage Form
LOTION
Route
TOPICAL
Active Ingredient
CLOBETASOL PROPIONATE
Tier
Unrated
Last Updated
2026-10-06
Reason for Shortage
Demand increase for the drug.
Other Products from MYLAN PHARMACEUTICALS ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02385473
333MG · DIN 02293269
10MG · DIN 02257955
40MG · DIN 02257963
DIN 02388138
DIN 02388146
50MG · DIN 02468549
2G · DIN 02407310
1G · DIN 02407302
50MG · DIN 02554666
100MG · DIN 02554674
100MG · DIN 02247244